欧盟青霉素过敏去标记分布成本效果分析

数据集获取（Figshare）

• 源站标题：Distributional Cost-Effectiveness Analysis of Penicillin Allergy De-labelling in the European Union
• DOI：10.6084/m9.figshare.29975668.v2
• 发布日期：2025-09-09
• 文件数：7 个
• 文件总体积：189.30 KB
• 源站页面：https://figshare.com/articles/dataset/Distributional_Cost-Effectiveness_Analysis_of_Penicillin_Allergy_De-labelling_in_the_European_Union/29975668

命令行下载

curl -L -o "README_figshare.md" "https://ndownloader.figshare.com/files/57385963"
curl -L -o "dcea_penicillin_delabelling.R" "https://ndownloader.figshare.com/files/57385966"
curl -L -o "EU_Validated_Country_Comparison.csv" "https://ndownloader.figshare.com/files/57385969"
curl -L -o "EU_Validated_Equity_Efficiency.png" "https://ndownloader.figshare.com/files/57385972"
curl -L -o "EU_Validated_Targeted_Results.csv" "https://ndownloader.figshare.com/files/57385975"
curl -L -o "EU_Validated_Uniform_Results.csv" "https://ndownloader.figshare.com/files/57385978"
curl -L -o "choropleth_map_generator.R" "https://ndownloader.figshare.com/files/57812149"

文件清单

• README_figshare.md（1.96 KB）
• dcea_penicillin_delabelling.R（31.79 KB）
• EU_Validated_Country_Comparison.csv（3.63 KB）
• EU_Validated_Equity_Efficiency.png（140.69 KB）
• EU_Validated_Targeted_Results.csv（3.53 KB）
• EU_Validated_Uniform_Results.csv（3.55 KB）
• choropleth_map_generator.R（4.15 KB）

文件总体积 189.30 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

This repository contains the R script and supporting materials for a distributional cost-effectiveness analysis (DCEA) of penicillin allergy de-labelling across the 27 EU member states. The model compares uniform versus targeted rollout strategies, quantifying both efficiency (QALYs, cost savings) and equity (equally distributed equivalent QALYs, equity-weighted net health benefit) outcomes.
Inputs include demographic data from Eurostat Demographics 2025 and antimicrobial resistance indices from the ECDC EARS-Net Annual Epidemiological Report 2023. Conservative effectiveness and cost parameters were derived from peer-reviewed literature.
The outputs include incremental QALYs, cost savings, net health benefits, equity-weighted outcomes, probabilistic sensitivity analyses, and an equity–efficiency visualization.

许可

MIT

引用

学术使用请引用 DOI 10.6084/m9.figshare.29975668.v2（source: https://figshare.com/articles/dataset/Distributional_Cost-Effectiveness_Analysis_of_Penicillin_Allergy_De-labelling_in_the_European_Union/29975668）。